The emergence of central respiratory events during PAP titration for treatment of obstructive sleep apnea is best described as

The emergence of central respiratory events during PAP titration for treatment of obstructive sleep apnea is best described as

• A. Mixed sleep apnea
• B. Complex sleep apnea
• C. Hypoventilation syndrome
• D. Cheyne-stokes breathing

Answer: (B)

During PAP titration for obstructive sleep apnea, central respiratory events that suddenly appear are characteristic of complex sleep apnea. This term, often called treatment-emergent central sleep apnea, describes the new central pauses that can emerge when airway pressure is applied and obstructive events are being treated. The PAP therapy can alter respiratory control—sometimes lowering CO2 below the threshold needed to drive breathing in susceptible individuals—unmasking central apneas or creating a mixed pattern. While the central events may persist in some patients, the key point is that they are induced or revealed by the therapy itself. Other options don’t fit as neatly: mixed sleep apnea refers to a combination of obstructive and central events but isn’t specifically about central events emerging due to PAP. Hypoventilation syndrome is a chronic, CO2-retaining condition not defined by therapy-induced central apneas. Cheyne-Stokes breathing is a distinct oscillatory pattern typically seen with certain cardiac or neurological conditions and isn’t the typical description of central events emerging during PAP titration.

During PAP titration for obstructive sleep apnea, central respiratory events that suddenly appear are characteristic of complex sleep apnea. This term, often called treatment-emergent central sleep apnea, describes the new central pauses that can emerge when airway pressure is applied and obstructive events are being treated. The PAP therapy can alter respiratory control—sometimes lowering CO2 below the threshold needed to drive breathing in susceptible individuals—unmasking central apneas or creating a mixed pattern. While the central events may persist in some patients, the key point is that they are induced or revealed by the therapy itself.

Other options don’t fit as neatly: mixed sleep apnea refers to a combination of obstructive and central events but isn’t specifically about central events emerging due to PAP. Hypoventilation syndrome is a chronic, CO2-retaining condition not defined by therapy-induced central apneas. Cheyne-Stokes breathing is a distinct oscillatory pattern typically seen with certain cardiac or neurological conditions and isn’t the typical description of central events emerging during PAP titration.